arrow
M

Massimo Serra

IRCCS Istituto Ortopedico Rizzoli
H指数:65
被引数:1.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Establishment and Characterization of OS-MET-R-092: A Novel Patient-Derived Cell Culture from an Osteosarcoma Bone Metastasis

建立和表征OS-MET-R-092:一种源自骨肉瘤骨转移的新型患者来源细胞培养物

2026-03-030
OAAI
VEGF Signaling Pathway Germline Polymorphisms as Prognostic Pharmacogenetic Biomarkers in Localized High-Grade Osteosarcoma Patients from the GEIS-33 Protocol

VEGF信号通路生殖系多态性作为来自GEIS-33方案局部高级别骨肉瘤患者的预后药物基因组学生物标志物

2025-12-050
OAAI
Extended molecular profiling in mesenchymal tumors: a consensus paper from the Italian Sarcoma Group

间质肿瘤的扩展分子分析:意大利肉瘤组共识论文

2025-09-230
PREAI
Underlying germline genetic architecture of pediatric sarcomas: Evaluating the role of common and rare variants in 4,160 patients
2024-03-220
PRE
phase II study for nonmetastatic extremity high-grade osteosarcoma in pediatric and AYA patients with a riskadapted strategy based on P-glycoprotein expression by the ISG (ISG/OS-2): A correlative study on tumor microenvironment
2023-10-010
OA
ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis (Sept, 10.1007/s13402-022-00713-5, 2022)
2022-11-091
OAAI
Phase 2 study for nonmetastatic extremity high-grade osteosarcoma in pediatric and adolescent and young adult patients with a risk-adapted strategy based on ABCB1/P-glycoprotein expression: An Italian Sarcoma Group trial (ISG/OS-2)
CANCER
IF5.1
2022-02-2419
OAAI
ABCB1/P-glycoprotein (Pgp) expression as stratification factor for treatment of patients with non metastatic extremity high grade osteosarcoma: An Italian Sarcoma Group (ISG) multicentric prospective trial (ISG/OS-2)
2020-09-012
OAAI
Hyaluronated liposomes containing H2S-releasing doxorubicin are effective against P-glycoprotein-positive/doxorubicin-resistant osteosarcoma cells and xenografts
2019-08-0149
OAAI